{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Coronaviruses",
      "Electrochemical signal",
      "Nucleic acid\u2013based detection",
      "Pathogen diagnostics",
      "Recognition element",
      "Serological testing"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33358285",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bios.2020.112905",
      "S0956-5663(20)30890-3"
    ],
    "Journal": {
      "ISSN": "1873-4235",
      "JournalIssue": {
        "Volume": "176",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar",
          "Day": "15"
        }
      },
      "Title": "Biosensors & bioelectronics",
      "ISOAbbreviation": "Biosens Bioelectron"
    },
    "ArticleTitle": "The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2.",
    "Pagination": {
      "StartPage": "112905",
      "MedlinePgn": "112905"
    },
    "Abstract": {
      "AbstractText": [
        "Electrochemical biosensors combine the selectivity of electrochemical signal transducers with the specificity of biomolecular recognition strategies. Although they have been broadly studied in different areas of diagnostics, they are not yet fully commercialized. During the COVID-19 pandemic, electrochemical platforms have shown the potential to address significant limitations of conventional diagnostic platforms, including accuracy, affordability, and portability. The advantages of electrochemical platforms make them a strong candidate for rapid point-of-care detection of SARS-CoV-2 infection by targeting not only viral RNA but antigens and antibodies. Herein, we reviewed advancements in electrochemical biosensing platforms towards the detection of SARS-CoV-2 through studying similar viruses."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biological Sciences Department, Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada. Electronic address: sahar.mahshid@sri.utoronto.ca."
          }
        ],
        "LastName": "Mahshid",
        "ForeName": "Sahar Sadat",
        "Initials": "SS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, McGill University, Montr\u00e9al, QC, H3A 0C3, Canada. Electronic address: s.elizabeth.flynn2@gmail.com."
          }
        ],
        "LastName": "Flynn",
        "ForeName": "Sarah Elizabeth",
        "Initials": "SE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, McGill University, Montr\u00e9al, QC, H3A 0C3, Canada. Electronic address: sara.mahshid@mcgill.ca."
          }
        ],
        "LastName": "Mahshid",
        "ForeName": "Sara",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Biosens Bioelectron",
    "NlmUniqueID": "9001289",
    "ISSNLinking": "0956-5663"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antigens, Viral"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods"
      ],
      "DescriptorName": "Biosensing Techniques"
    },
    {
      "QualifierName": [
        "diagnosis",
        "immunology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods"
      ],
      "DescriptorName": "COVID-19 Nucleic Acid Testing"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods"
      ],
      "DescriptorName": "COVID-19 Serological Testing"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods"
      ],
      "DescriptorName": "Electrochemical Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Point-of-Care Testing"
    },
    {
      "QualifierName": [
        "analysis",
        "genetics"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}